Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Lexaria Bioscience Corp (OP: LXRP)
0.5000 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 3:57 PM EST, Jan 24, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.5000
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.5000
Today's Range 0.5000 - 0.5000
52wk Range 0.3037 - 1.570
Shares Outstanding 71,772,305
Dividend Yield N/A
Performance
YTD
+36.24%
+36.24%
1 Month
+20.48%
+20.48%
3 Month
-24.81%
-24.81%
6 Month
-28.06%
-28.06%
1 Year
-63.77%
-63.77%
Top News
More News
Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category
category None
from TheNewswire.com - RSS (Media)
Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category
from ACCESSWIRE
More News
Read More
Lexaria Biosciences and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category
category None
from TheNewswire.com - RSS (Media)
Lexaria Bioscience Corp. and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category
from ACCESSWIRE
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Inks Licensing Deal with Smokeless Cannadips CBD Product Maker
from InvestorBrandNetwork
CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US
from InvestorBrandNetwork
Lexaria Provides Strategic Update from CEO
from ACCESSWIRE
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expects Sustainable Revenue Growth, Plans New Capital Markets Strategy in 2020
from InvestorBrandNetwork
Concerns About Vape Addiction, Injury Provide Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) with Opportunity
from InvestorBrandNetwork
Lexaria Provides Strategic Update from CEO
category None
from TheNewswire.com - RSS (Media)
CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Agreement to Provide DehydraTECH(TM) Technology to Cannadips CBD
from InvestorBrandNetwork
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.